Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal (Urology,Obsterics,Gynecology).
Phase of Trial: Phase IV
Latest Information Update: 31 Mar 2015
At a glance
- Drugs Fondaparinux sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- Sponsors GlaxoSmithKline
- 26 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Jul 2011 New trial record